Bioptimus
Bioptimus is a biotechnology company based in Paris, France, focused on developing multi-scale artificial intelligence (AI) foundation models for biology. Founded by experts from institutions like Google DeepMind and Novartis, the company aims to enhance biological research by integrating various biological data, from molecules to whole organisms, into comprehensive AI models. The flagship product, H-Optimus-0, is recognized as the world's largest foundation model for pathology. It excels in predicting gene expression from morphological data and accurately subtyping diseases, such as ovarian cancer. Bioptimus's models combine data modalities like imaging and genetics, facilitating a holistic understanding of complex biological systems. This innovative approach supports applications in drug discovery, disease outcome prediction, and the design of targeted therapies. Bioptimus collaborates with pharmaceutical companies, academic institutions, and the broader scientific community to advance research and innovation in biomedicine. The company is led by CEO Jean-Philippe Vert and has a strong leadership team with expertise in computational biology and AI-driven drug discovery.
Work at Bioptimus in HR or recruiting? Claim this page
Headcount trend
Bioptimus went from 0 employees in Jul 2023 to 2 in Jun 2025.
Headcount data through Jun 2025
Org structure
Headcount by department
Peer reviews
Worked with someone at Bioptimus?
Anonymous peer reviews on OffTheRecord
Similar companies
Bioptimus FAQ
How many employees does Bioptimus have?
Bioptimus has about 2 employees, unchanged over the 3 months to Jun 2025.
Data from Company Prospectus, DOL LCA disclosures, WARN notices and 6figr salary profiles.